Nicholas Hoffman & Company’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $412K | Hold |
3,475
| – | – | 0.01% | 257 |
|
|
2026
Q1 | $361K | Hold |
3,475
| – | – | 0.01% | 266 |
|
|
2025
Q4 | $363K | Hold |
3,475
| – | – | 0.01% | 254 |
|
|
2025
Q3 | $321K | Hold |
3,475
| – | – | 0.01% | 260 |
|
|
2025
Q2 | $278K | Hold |
3,475
| – | – | 0.01% | 263 |
|
|
2025
Q1 | $301K | Hold |
3,475
| – | – | 0.01% | 246 |
|
|
2024
Q4 | $287K | Hold |
3,475
| – | – | 0.01% | 245 |
|
|
2024
Q3 | $302K | Hold |
3,475
| – | – | 0.01% | 249 |
|
|
2024
Q2 | $286K | Hold |
3,475
| – | – | 0.01% | 247 |
|
|
2024
Q1 | $279K | Hold |
3,475
| – | – | 0.01% | 247 |
|
|
2023
Q4 | $264K | Hold |
3,475
| – | – | 0.02% | 244 |
|
|
2023
Q3 | $251K | Hold |
3,475
| – | – | 0.02% | 232 |
|
|
2023
Q2 | $263K | Hold |
3,475
| – | – | 0.01% | 237 |
|
|
2023
Q1 | $264K | Hold |
3,475
| – | – | 0.02% | 236 |
|
|
2022
Q4 | $273K | Hold |
3,475
| – | – | 0.03% | 222 |
|
|
2022
Q3 | $248K | Hold |
3,475
| – | – | 0.01% | 219 |
|
|
2022
Q2 | $261K | Hold |
3,475
| – | – | 0.01% | 218 |
|
|
2022
Q1 | $277K | Hold |
3,475
| – | – | 0.01% | 239 |
|
|
2021
Q4 | $282K | Hold |
3,475
| – | – | 0.01% | 235 |
|
|
2021
Q3 | $269K | Hold |
3,475
| – | – | 0.05% | 230 |
|
|
2021
Q2 | $280K | Hold |
3,475
| – | – | 0.05% | 221 |
|
|
2021
Q1 | $274K | Sell |
3,475
-325
| -9% | -$25.4K | 0.06% | 206 |
|
|
2020
Q4 | $271K | Hold |
3,800
| – | – | 0.06% | 191 |
|
|
2020
Q3 | $243K | Hold |
3,800
| – | – | 0.06% | 172 |
|
|
2020
Q2 | $246K | Hold |
3,800
| – | – | 0.07% | 172 |
|
|
2020
Q1 | $209K | Hold |
3,800
| – | – | 0.07% | 169 |
|
|
2019
Q4 | $246K | Hold |
3,800
| – | – | 0.07% | 174 |
|
|
2019
Q3 | $215K | Hold |
3,800
| – | – | 0.07% | 178 |
|
|
2019
Q2 | $229K | Hold |
3,800
| – | – | 0.07% | 168 |
|
|
2019
Q1 | $248K | Hold |
3,800
| – | – | 0.08% | 154 |
|
|
2018
Q4 | $237K | Hold |
3,800
| – | – | 0.08% | 155 |
|
|
2018
Q3 | $279K | Hold |
3,800
| – | – | 0.09% | 154 |
|
|
2018
Q2 | $255K | Hold |
3,800
| – | – | 0.09% | 149 |
|
|
2018
Q1 | $237K | Hold |
3,800
| – | – | 0.09% | 152 |
|
|
2017
Q4 | $244K | Hold |
3,800
| – | – | 0.1% | 150 |
|
|
2017
Q3 | $248K | Hold |
3,800
| – | – | 0.1% | 137 |
|
|
2017
Q2 | $239K | Hold |
3,800
| – | – | 0.11% | 128 |
|
|
2017
Q1 | $223K | Hold |
3,800
| – | – | 0.1% | 138 |
|
|
2016
Q4 | $218K | Hold |
3,800
| – | – | 0.11% | 143 |
|
|
2016
Q3 | $234K | Hold |
3,800
| – | – | 0.13% | 125 |
|
|
2016
Q2 | $241K | Buy |
+3,800
| New | +$239K | 0.14% | 117 |
|
Other funds holding PJP
JGCM
DBIA
TC
IFWM
Nicholas Hoffman & Company's PJP Position: Q2 2026 in Review
Nicholas Hoffman & Company held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 3,475 shares worth $412K. The position accounts for 0.01% of the portfolio, ranked #257.
Nicholas Hoffman & Company first reported a position in PJP in Q2 2016 and has held it in 41 quarters since. 63 funds tracked by Wall St. Rank hold PJP as of Q2 2026.
- Nicholas Hoffman & Company held 3,475 shares of Invesco Pharmaceuticals ETF worth $412K as of Q2 2026.
- Nicholas Hoffman & Company left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
- Invesco Pharmaceuticals ETF made up 0.01% of Nicholas Hoffman & Company's portfolio in Q2 2026, its #257 holding.
- Nicholas Hoffman & Company first reported a position in Invesco Pharmaceuticals ETF in Q2 2016 and has held it in 41 quarters since.
- 63 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.
Based on Nicholas Hoffman & Company's 13F filing for Q2 2026, filed 4 Aug 2026.